Christopher F. Mojcik

Christopher F. Mojcik is a declared insider of Alexion Pharmaceuticals Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 9 January 2006 to 29 May 2007, the count stands at 69 filings.

The open-market side counts 1 purchase for €176k alongside 63 sales for €3.5M. On balance, insiders were net sellers of €3.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 1 option exercise. 2007 to date brings 1 purchase and 63 sales.

The latest filing, published on 31 May 2007, reports an open-market sale of €316k in Alexion Pharmaceuticals Inc. The last insider purchase was made public on 31 May 2007, 7,101 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.